Search

everythinglearnresearchcommunity

for

Search:↓

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Some drugs can cause hair loss or growth, but hair usually returns to normal after stopping the drug.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Leukemia can sometimes appear as unusual skin issues in children.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

The combination treatment effectively and safely cured scalp microsporia in children faster and prevented recurrence.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

Patients with hematologic cancer had mild anxiety, low surgical knowledge, and the pandemic increased their anxiety.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Hodgkin's lymphoma can show up as hair loss.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Vorasidenib can cause unusual hair growth.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

Bimatoprost effectively improves eyelashes in chemotherapy patients.